Actualités

A critical clause in the CEO’s Tesla stock award would wipe away lofty performance targets if a merger happened.

Securities and Exchange Commission on Monday brought settled charges of fraud against Adit Ventures Management, its founder and three partners in ‌connection with pre-IPO investments in companies including Klarna and SpaceX, the agency said in a release. The ‌SEC alleged that the investment adviser had used "false claims and promises" to solicit investments in Adit-managed funds and used client money for the firm's ​own benefit, including by taking unsecured loans on favorable terms without dis

(Bloomberg) -- Investment adviser Adit Ventures and co-founder Eric Munson were accused by the US Securities and Exchange Commission of making false claims about investments and overcharging clients with millions of dollars in undisclosed fees to buy shares of companies including SpaceX and Klarna before they were offered to the public.Most Read from BloombergChina Unleashes $28 Trillion Capital Markets to Challenge US in AIStocks Churn as Hormuz Standoff Spurs Rally in Oil: Markets WrapIran Sha

With shares now trading at a steep discount, is this a generational buying opportunity?

Strategic buyers are chasing scarce real-time AI technology

Ark Invest on Monday said that SPCX’s 14% drop on Wednesday last week overlooked SpaceX’s $28.5 trillion total addressable market outlined in its IPO filings.

The shares briefly moved above their offering price before renewed supply concerns erased an early advance.

The rocket company's stock hit its offering price Monday for the first time since July 15, recovering from a close as low as $108.27

SpaceX stock just clawed back to its IPO price on blowout earnings, but a record short position and a trillion dollars in unlocking insider shares suggest the real story behind this rally is far messier than the headlines.

Initial public offerings won't unlock instant wealth for retail investors.

Shares of SpaceX on Monday rose above $135, the price at which the company sold shares to the public in mid-June, for the first time since July 16.

The retail investor tide may be turning on SpaceX after 59 days in the public markets.

Tech stock news for the week of Aug. 10

(Bloomberg) -- Lyntris Inc. and some of its backers are seeking to raise as much as $528 million in an initial public offering, joining a wave of listings driven by demand for defense equipment.Most Read from BloombergChina Unleashes $28 Trillion Capital Markets to Challenge US in AIIran Shakes Up Security Team After Saying Oman Deal ‘Very Close’Stocks Churn as Oil Advance Boosts Treasury Yields: Markets WrapTrump Amps Up Pressure on Billionaire Sargeant to Exit VenezuelaBehind Bessent Moves, Wa

SPCX (NASDAQ: SPCX) closed Friday, August 7 at $133.11, capping a weekly gain of 22.8% from the $108.37 close on July 31. That Friday session alone delivered a 15.83% surge — the stock’s largest single-day advance since its June 12 debut.

Barrick earnings fell short as oil prices pushed up costs. A Newmont deal could ease the way for a North America IPO.

Investing.com -- Retail investors sold SpaceX stock on a net basis Friday for the first time since the company's June initial public offering, according to Vanda Research data.

Sell-side analysts have parked on Hold while some of the sharpest event-driven hedge funds in the business are quietly building complex positions around Norfolk Southern's pending merger. The two camps are not fighting over fundamentals. They are betting on very different things entirely.

CyrusOne, a data center operator owned by KKR and BlackRock's Global Infrastructure Partners, is preparing for an initial public offering ‌as early as 2027, in what could be one of the biggest IPOs ‌in the sector in recent years, according to people familiar with the matter. The private equity firms met investment banks ​including Goldman Sachs and Morgan Stanley last week and the banks pitched for roles on the IPO, the people said, asking not to be identified because the discussions are confidential.

SpaceX has struggled in recent weeks.

Medicine and manufacturing technology provider Novanta (NASDAQ:NOVT) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 10.3% year on year to $265.8 million. On top of that, next quarter’s revenue guidance ($302 million at the midpoint) was surprisingly good and 14.9% above what analysts were expecting. Its non-GAAP profit of $0.89 per share was 7.2% above analysts’ consensus estimates.

Tesla (NasdaqGS:TSLA) is at the center of new market rumors that it may separate its China business and prepare for a potential merger with SpaceX. Unconfirmed options reported for Tesla's China operations include a possible sale, spinoff, or closure ahead of any combination with SpaceX. CEO Elon Musk and Tesla representatives have publicly denied that such merger and separation talks are taking place. The speculation focuses investor attention on Tesla's access to China-based supply chains,...

The answer to who is funding the AI build-out could matter far more for cash-burning AI companies than for Nvidia itself.

The newly public companies offer investors a choice between the hot space sector and the emerging quantum computing market.

Investor and television personality Kevin O’Leary said he may begin buying SpaceX shares once post-IPO volatility settles, arguing that the bigger long-term opportunity lies in Elon Musk potentially connecting SpaceX with Tesla Inc., artificial intelligence, robotics and autonomous driving. O’Leary...

Crypto pullback and merger focus reshape Trump Media & Technology Group’s story Trump Media & Technology Group (DJT) is refocusing its ambitions after dialing back a planned cryptocurrency expansion, dissolving a CRO token venture with Crypto.com and prioritizing completion of its proposed merger with nuclear fusion firm TAE. This shift places more attention on how the TAE deal could influence Trump Media & Technology Group’s business mix, alongside its existing Truth Social, Truth+ streaming...

Novanta (NasdaqGS:NOVT) has closed its acquisition of RiverPoint Medical, the largest deal in the company's history. The transaction expands Novanta's exposure to medical end markets and is expected to be immediately accretive to revenue growth and margins. Management is accelerating a manufacturing restructuring plan alongside the RiverPoint integration, with potential long-term effects on efficiency and profitability. For investors watching how medical technology companies scale up and...

Chipotle has posted several quarters of revenue growth, while Disney's larger sales base shifts with seasonal swings.

This non-discretionary sale was tied to equity vesting tax obligations.

This insider retains 124,261 shares worth $11.84 million after non-discretionary equity vesting.